List of Tables
Table 1. Global Cyclin Dependent Kinase 1 Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Cyclin Dependent Kinase 1 Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Cyclin Dependent Kinase 1 Market Competitive Situation by Manufacturers in 2022
Table 4. Global Cyclin Dependent Kinase 1 Sales (K Pcs) of Key Manufacturers (2018-2023)
Table 5. Global Cyclin Dependent Kinase 1 Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Cyclin Dependent Kinase 1 Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Cyclin Dependent Kinase 1 Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Cyclin Dependent Kinase 1 Average Price (USD/Pcs) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Cyclin Dependent Kinase 1, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Cyclin Dependent Kinase 1, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Cyclin Dependent Kinase 1, Product Type & Application
Table 12. Global Key Manufacturers of Cyclin Dependent Kinase 1, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Cyclin Dependent Kinase 1 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cyclin Dependent Kinase 1 as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Cyclin Dependent Kinase 1 Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Cyclin Dependent Kinase 1 Sales by Region (2018-2023) & (K Pcs)
Table 18. Global Cyclin Dependent Kinase 1 Sales Market Share by Region (2018-2023)
Table 19. Global Cyclin Dependent Kinase 1 Sales by Region (2024-2029) & (K Pcs)
Table 20. Global Cyclin Dependent Kinase 1 Sales Market Share by Region (2024-2029)
Table 21. Global Cyclin Dependent Kinase 1 Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Cyclin Dependent Kinase 1 Revenue Market Share by Region (2018-2023)
Table 23. Global Cyclin Dependent Kinase 1 Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Cyclin Dependent Kinase 1 Revenue Market Share by Region (2024-2029)
Table 25. North America Cyclin Dependent Kinase 1 Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Cyclin Dependent Kinase 1 Sales by Country (2018-2023) & (K Pcs)
Table 27. North America Cyclin Dependent Kinase 1 Sales by Country (2024-2029) & (K Pcs)
Table 28. North America Cyclin Dependent Kinase 1 Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Cyclin Dependent Kinase 1 Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Cyclin Dependent Kinase 1 Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Cyclin Dependent Kinase 1 Sales by Country (2018-2023) & (K Pcs)
Table 32. Europe Cyclin Dependent Kinase 1 Sales by Country (2024-2029) & (K Pcs)
Table 33. Europe Cyclin Dependent Kinase 1 Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Cyclin Dependent Kinase 1 Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Cyclin Dependent Kinase 1 Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Cyclin Dependent Kinase 1 Sales by Region (2018-2023) & (K Pcs)
Table 37. Asia Pacific Cyclin Dependent Kinase 1 Sales by Region (2024-2029) & (K Pcs)
Table 38. Asia Pacific Cyclin Dependent Kinase 1 Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Cyclin Dependent Kinase 1 Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Cyclin Dependent Kinase 1 Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Cyclin Dependent Kinase 1 Sales by Country (2018-2023) & (K Pcs)
Table 42. Latin America Cyclin Dependent Kinase 1 Sales by Country (2024-2029) & (K Pcs)
Table 43. Latin America Cyclin Dependent Kinase 1 Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Cyclin Dependent Kinase 1 Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Cyclin Dependent Kinase 1 Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Cyclin Dependent Kinase 1 Sales by Country (2018-2023) & (K Pcs)
Table 47. Middle East & Africa Cyclin Dependent Kinase 1 Sales by Country (2024-2029) & (K Pcs)
Table 48. Middle East & Africa Cyclin Dependent Kinase 1 Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Cyclin Dependent Kinase 1 Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Cyclin Dependent Kinase 1 Sales (K Pcs) by Type (2018-2023)
Table 51. Global Cyclin Dependent Kinase 1 Sales (K Pcs) by Type (2024-2029)
Table 52. Global Cyclin Dependent Kinase 1 Sales Market Share by Type (2018-2023)
Table 53. Global Cyclin Dependent Kinase 1 Sales Market Share by Type (2024-2029)
Table 54. Global Cyclin Dependent Kinase 1 Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Cyclin Dependent Kinase 1 Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Cyclin Dependent Kinase 1 Revenue Market Share by Type (2018-2023)
Table 57. Global Cyclin Dependent Kinase 1 Revenue Market Share by Type (2024-2029)
Table 58. Global Cyclin Dependent Kinase 1 Price (USD/Pcs) by Type (2018-2023)
Table 59. Global Cyclin Dependent Kinase 1 Price (USD/Pcs) by Type (2024-2029)
Table 60. Global Cyclin Dependent Kinase 1 Sales (K Pcs) by Application (2018-2023)
Table 61. Global Cyclin Dependent Kinase 1 Sales (K Pcs) by Application (2024-2029)
Table 62. Global Cyclin Dependent Kinase 1 Sales Market Share by Application (2018-2023)
Table 63. Global Cyclin Dependent Kinase 1 Sales Market Share by Application (2024-2029)
Table 64. Global Cyclin Dependent Kinase 1 Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Cyclin Dependent Kinase 1 Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Cyclin Dependent Kinase 1 Revenue Market Share by Application (2018-2023)
Table 67. Global Cyclin Dependent Kinase 1 Revenue Market Share by Application (2024-2029)
Table 68. Global Cyclin Dependent Kinase 1 Price (USD/Pcs) by Application (2018-2023)
Table 69. Global Cyclin Dependent Kinase 1 Price (USD/Pcs) by Application (2024-2029)
Table 70. Astex Pharmaceuticals Inc Corporation Information
Table 71. Astex Pharmaceuticals Inc Description and Business Overview
Table 72. Astex Pharmaceuticals Inc Cyclin Dependent Kinase 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 73. Astex Pharmaceuticals Inc Cyclin Dependent Kinase 1 Product
Table 74. Astex Pharmaceuticals Inc Recent Developments/Updates
Table 75. ChoDang Pharm Co Ltd Corporation Information
Table 76. ChoDang Pharm Co Ltd Description and Business Overview
Table 77. ChoDang Pharm Co Ltd Cyclin Dependent Kinase 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 78. ChoDang Pharm Co Ltd Cyclin Dependent Kinase 1 Product
Table 79. ChoDang Pharm Co Ltd Recent Developments/Updates
Table 80. Presage Biosciences Inc Corporation Information
Table 81. Presage Biosciences Inc Description and Business Overview
Table 82. Presage Biosciences Inc Cyclin Dependent Kinase 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 83. Presage Biosciences Inc Cyclin Dependent Kinase 1 Product
Table 84. Presage Biosciences Inc Recent Developments/Updates
Table 85. Tiziana Life Sciences Plc Corporation Information
Table 86. Tiziana Life Sciences Plc Description and Business Overview
Table 87. Tiziana Life Sciences Plc Cyclin Dependent Kinase 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 88. Tiziana Life Sciences Plc Cyclin Dependent Kinase 1 Product
Table 89. Tiziana Life Sciences Plc Recent Developments/Updates
Table 90. Tragara Pharmaceuticals Inc Corporation Information
Table 91. Tragara Pharmaceuticals Inc Description and Business Overview
Table 92. Tragara Pharmaceuticals Inc Cyclin Dependent Kinase 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 93. Tragara Pharmaceuticals Inc Cyclin Dependent Kinase 1 Product
Table 94. Tragara Pharmaceuticals Inc Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Cyclin Dependent Kinase 1 Distributors List
Table 98. Cyclin Dependent Kinase 1 Customers List
Table 99. Cyclin Dependent Kinase 1 Market Trends
Table 100. Cyclin Dependent Kinase 1 Market Drivers
Table 101. Cyclin Dependent Kinase 1 Market Challenges
Table 102. Cyclin Dependent Kinase 1 Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Cyclin Dependent Kinase 1
Figure 2. Global Cyclin Dependent Kinase 1 Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Cyclin Dependent Kinase 1 Market Share by Type in 2022 & 2029
Figure 4. AT-7519 Product Picture
Figure 5. CD-650 Product Picture
Figure 6. Milciclib Product Picture
Figure 7. Others Product Picture
Figure 8. Global Cyclin Dependent Kinase 1 Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Cyclin Dependent Kinase 1 Market Share by Application in 2022 & 2029
Figure 10. Relapsed Chronic Lymphocytic Leukemia
Figure 11. Gliosarcoma
Figure 12. Lymphoma
Figure 13. Others
Figure 14. Global Cyclin Dependent Kinase 1 Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Cyclin Dependent Kinase 1 Market Size (2018-2029) & (US$ Million)
Figure 16. Global Cyclin Dependent Kinase 1 Sales (2018-2029) & (K Pcs)
Figure 17. Global Cyclin Dependent Kinase 1 Average Price (USD/Pcs) & (2018-2029)
Figure 18. Cyclin Dependent Kinase 1 Report Years Considered
Figure 19. Cyclin Dependent Kinase 1 Sales Share by Manufacturers in 2022
Figure 20. Global Cyclin Dependent Kinase 1 Revenue Share by Manufacturers in 2022
Figure 21. The Global 5 and 10 Largest Cyclin Dependent Kinase 1 Players: Market Share by Revenue in 2022
Figure 22. Cyclin Dependent Kinase 1 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 23. Global Cyclin Dependent Kinase 1 Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 24. North America Cyclin Dependent Kinase 1 Sales Market Share by Country (2018-2029)
Figure 25. North America Cyclin Dependent Kinase 1 Revenue Market Share by Country (2018-2029)
Figure 26. U.S. Cyclin Dependent Kinase 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Canada Cyclin Dependent Kinase 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Europe Cyclin Dependent Kinase 1 Sales Market Share by Country (2018-2029)
Figure 29. Europe Cyclin Dependent Kinase 1 Revenue Market Share by Country (2018-2029)
Figure 30. Germany Cyclin Dependent Kinase 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. France Cyclin Dependent Kinase 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. U.K. Cyclin Dependent Kinase 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Italy Cyclin Dependent Kinase 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Russia Cyclin Dependent Kinase 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Asia Pacific Cyclin Dependent Kinase 1 Sales Market Share by Region (2018-2029)
Figure 36. Asia Pacific Cyclin Dependent Kinase 1 Revenue Market Share by Region (2018-2029)
Figure 37. China Cyclin Dependent Kinase 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Japan Cyclin Dependent Kinase 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. South Korea Cyclin Dependent Kinase 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. India Cyclin Dependent Kinase 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Australia Cyclin Dependent Kinase 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Taiwan Cyclin Dependent Kinase 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Indonesia Cyclin Dependent Kinase 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Thailand Cyclin Dependent Kinase 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Malaysia Cyclin Dependent Kinase 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Philippines Cyclin Dependent Kinase 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Latin America Cyclin Dependent Kinase 1 Sales Market Share by Country (2018-2029)
Figure 48. Latin America Cyclin Dependent Kinase 1 Revenue Market Share by Country (2018-2029)
Figure 49. Mexico Cyclin Dependent Kinase 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Brazil Cyclin Dependent Kinase 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Argentina Cyclin Dependent Kinase 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Middle East & Africa Cyclin Dependent Kinase 1 Sales Market Share by Country (2018-2029)
Figure 53. Middle East & Africa Cyclin Dependent Kinase 1 Revenue Market Share by Country (2018-2029)
Figure 54. Turkey Cyclin Dependent Kinase 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Saudi Arabia Cyclin Dependent Kinase 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. UAE Cyclin Dependent Kinase 1 Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. Global Sales Market Share of Cyclin Dependent Kinase 1 by Type (2018-2029)
Figure 58. Global Revenue Market Share of Cyclin Dependent Kinase 1 by Type (2018-2029)
Figure 59. Global Cyclin Dependent Kinase 1 Price (USD/Pcs) by Type (2018-2029)
Figure 60. Global Sales Market Share of Cyclin Dependent Kinase 1 by Application (2018-2029)
Figure 61. Global Revenue Market Share of Cyclin Dependent Kinase 1 by Application (2018-2029)
Figure 62. Global Cyclin Dependent Kinase 1 Price (USD/Pcs) by Application (2018-2029)
Figure 63. Cyclin Dependent Kinase 1 Value Chain
Figure 64. Cyclin Dependent Kinase 1 Production Process
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Distributors Profiles
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed